814
Participants
Start Date
February 6, 2017
Primary Completion Date
February 19, 2019
Study Completion Date
July 12, 2019
Insulin Analog Mid Mixture
Administered SC
Basal Insulin Analog
Administered SC
Beijing Huaxin Hospital, Beijing
China Meitan General Hospital, Chaoyang
Peking University Peoples Hospital, Beijing
Beijing LuHe Hospital Capital Medical University, Beijing
Peking University International Hospital, Beijing
Beijing Yanhua hospital, Fangshan
Shanghai Yangpu District Central Hospital, Shanghai
Shanghai Pudong New Area Gongli Hospital, Shanghai
Shanghai Pudong New District Zhoupu Hospital, Shanghai
Nanjing TCM hospital, Nanjing
Jiang Su Province Official Hospital, Nanjing
Nanjing Jiangbei Hospital, Nanjing
Nanjing Jiangning Hospital, Nanjing
Changzhou No.2 People's Hospital, Changzhou
The second People's hospital of Wuxi, Wuxi
Xuzhou central Hospital, Xuzhou
Taizhou City People Hospital, Taizhou
Qingdao Municipal Hospital, Qingdao
Taian City Central Hospital, Taian
Tianjin First Central Hospital, Nankai
Zhejiang Provincial People's Hospital, Hangzhou
Ningbo First Hospital, Ningbo
Wuhan Union (Xiehe) Hospital, Wuhan
People's Hospital of Henan Province, Zhengzhou
The 1st Affiliated Hospital of Henan Science and technology, Luoyang
The 1st Hospital with Guangdong Pharmaceutical University, Yuexiu
Shenzhen City People Hospital, Shenzhen
The Third Affiliated Hospital of Chengdu University of TCM, Chengdu
Affiliated Hospital of North Sichuan Medical College, Nanchong
Southwest Medical University Affiliated Hospital, Luzhou
The 2nd Hospital of Lanzhou University, Lanzhou
Beijing Hai Dian Hospital, Beijing
Eli Lilly and Company
INDUSTRY